Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02678182
Title Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial (PLATFORM)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Royal Marsden NHS Foundation Trust
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

esophagus adenocarcinoma

Therapies

Durvalumab

Rucaparib

Capecitabine

Trastuzumab

Capecitabine + Ramucirumab

Age Groups: senior | adult
Covered Countries


No variant requirements are available.